Iterum Therapeutics (ITRM) Q3 2024 Earnings

14AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.93
-0.62
-0.31
-0

Details

Expected EPS
-0.45
Actual EPS
-0.23
Surprise EPS
0.22
Surprise Percent
+48.89%

Description

Iterum Therapeutics (ITRM) has reported earnings of -0.23 per share for Q3 2024.

0 Comments

Share your thoughts